Hosted on MSN3mon
FDA approves weight-loss drug Zepbound to treat sleep apneaDec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback